Published in Nature on May 08, 1997
Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol (2004) 1.39
Characterization of Nef-CXCR4 interactions important for apoptosis induction. J Virol (2004) 1.24
The evolution of HIV: inferences using phylogenetics. Mol Phylogenet Evol (2011) 0.94
A method to estimate the efficiency of gene expression from an integrated retroviral vector. Retrovirology (2006) 0.76
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell (1989) 9.66
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
DNA recombination during PCR. Nucleic Acids Res (1990) 7.73
HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr (1989) 6.16
Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus. Cell (1986) 6.07
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes. J Virol (1991) 5.03
Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature (1990) 5.02
AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (1987) 4.96
Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol (1991) 2.91
A novel type of human papillomavirus associated with genital neoplasias. Nature (1986) 2.89
G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc Natl Acad Sci U S A (1994) 2.52
Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22
Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc Natl Acad Sci U S A (1994) 2.21
Genetic organization of gibbon ape leukemia virus. Virology (1989) 2.18
RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis (1994) 2.08
Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol (1994) 2.07
HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell (1994) 2.07
Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol (1995) 1.95
Preferential codon usage in genes. Gene (1981) 1.90
Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol (1992) 1.89
In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur J Immunol (1991) 1.72
Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc Natl Acad Sci U S A (1984) 1.71
Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5. Proc Natl Acad Sci U S A (1983) 1.69
Hypermutagenic PCR involving all four transitions and a sizeable proportion of transversions. Nucleic Acids Res (1996) 1.67
Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc Natl Acad Sci U S A (2000) 1.65
Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst (2001) 1.64
Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc Natl Acad Sci U S A (2001) 1.61
Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo. J Virol (1991) 1.55
Nonhomogeneous distribution of human immunodeficiency virus type 1 proviruses in the spleen. J Virol (1992) 1.50
HIV genetic variation is directed and restricted by DNA precursor availability. J Mol Biol (1997) 1.48
Nucleotide sequence and evolution of ETn elements. Proc Natl Acad Sci U S A (1987) 1.42
Peer reviewers could do much better. Nature (1997) 1.40
A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot. AIDS (1989) 1.40
Exploring the functional robustness of an enzyme by in vitro evolution. EMBO J (1996) 1.38
Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol (1995) 1.32
Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene (1998) 1.28
Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence. Virology (1992) 1.27
Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.18
Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J Virol (1994) 1.18
The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315. Biochem J (1977) 1.17
Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination. Nat Med (1998) 1.14
Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation. Virology (1997) 1.11
Somatic hypermutation of the T cell receptor V beta gene in microdissected splenic white pulps from HIV-1-positive patients. Eur J Immunol (1998) 1.11
Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315. Biochem J (1976) 1.09
Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction. Nucleic Acids Res (1995) 1.07
Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes. J Immunol (1988) 1.07
AIDS. Virological mayhem. Nature (1995) 1.06
Structure of an antibody combining site by magnetic resonance. Nature (1977) 1.06
Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination. Immunodefic Rev (1989) 1.06
The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology (1995) 1.04
Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. Virology (1992) 1.04
Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood (1996) 1.01
Polio vaccine samples not linked to AIDS. Nature (2001) 1.01
Viral burden in AIDS. Nature (1993) 1.01
Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo. J Virol (2000) 1.01
Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol (1995) 1.00
Ambiguous base pairing of the purine analogue 1-(2-deoxy-beta-D-ribofuranosyl)-imidazole-4-carboxamide during PCR. Nucleic Acids Res (1996) 0.99
Hepatitis B virus DNA in Dane particles: evidence for the presence of replicative intermediates. J Infect Dis (1985) 0.97
Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping. Biochem J (1977) 0.97
Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene (1996) 0.97
Are RNA viruses adapting or merely changing? J Mol Evol (2000) 0.95
High-resolution structure of an HIV-1 quasispecies: identification of novel coding sequences. AIDS (1992) 0.94
HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients. Blood (2001) 0.94
The gross architecture of an antibody-combining site as determined by spin-label mapping. Biochem J (1977) 0.92
HIV. One on one meets two. Nature (1996) 0.92
Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315. Biochem J (1977) 0.91
HIV-1 gp120 sequences from a doubly infected drug user. AIDS Res Hum Retroviruses (1995) 0.91
Relationship of AIDS to other retroviruses. Nature (1985) 0.90
Manganese cations increase the mutation rate of human immunodeficiency virus type 1 ex vivo. J Gen Virol (1999) 0.90
Phylogenetic reconstruction of intrapatient evolution of human immunodeficiency virus type 1: predominance of drift and purifying selection. J Gen Virol (2001) 0.89
G --> A hypermutation does not result from polymerase chain reaction. AIDS Res Hum Retroviruses (1997) 0.88
Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies. J Infect Dis (1992) 0.87
More ado about HIV's origins. Nat Med (1998) 0.87
Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population. J Viral Hepat (2012) 0.85
Insertion/deletion frequencies match those of point mutations in the hypervariable regions of the simian immunodeficiency virus surface envelope gene. J Gen Virol (2001) 0.84
The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape. Proc Natl Acad Sci U S A (2001) 0.83
Human immunodeficiency virus type 1 reverse transcriptase tG:T mispair formation on RNA and DNA templates with mismatched primers: a kinetic and thermodynamic study. EMBO J (1995) 0.83
Quantification of HTLV-1 proviral copy number in peripheral blood of symptomless carriers from the French West Indies. J Acquir Immune Defic Syndr (1992) 0.83
Fate of direct and inverted repeats in the RNA hypermutagenesis reaction. Nucleic Acids Res (1996) 0.82
Sequence of the rhesus monkey T-cell receptor beta chain diversity and joining loci. Immunogenetics (1996) 0.80
Mission now possible for AIDS fund. Nature (2001) 0.80
Organization and expression of hepatitis B sequences cloned from hepatocellular carcinoma tissue DNA. J Cell Biochem (1982) 0.79
Differential evolution of the Saccharomyces cerevisiae DUP240 paralogs and implication of recombination in phylogeny. Nucleic Acids Res (2004) 0.79
Simulating pseudogene evolution in vitro: determining the true number of mutations in a lineage. Proc Natl Acad Sci U S A (2001) 0.79
Difficulties in determining accurate molecular motion parameters from proton relaxation enhancement measurements as illustrated by the immunoglobulin G-Gd(III) system. Eur J Biochem (1976) 0.78
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Dev Biol Stand (1990) 0.78
Solution structure of a homopyrimidine: homopurine dodecamer encoded by the HIV-1 envelope gene: NMR and molecular simulation studies. Biochemistry (1995) 0.77
Breaching barriers. Nat Med (1996) 0.77
Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes. Adv Exp Med Biol (1995) 0.77
Small-angle neutron scattering studies of the conformation of myeloma protein MOPC315 and its Fab fragment, and the interaction with a monovalent dinitrophenyl hapten. Proc R Soc Lond B Biol Sci (1981) 0.77
Hypermutagenic in vitro transcription employing biased NTP pools and manganese cations. Gene (1997) 0.77
Application of ring-current theory based on the Johnson-Bovey equation to the aromatic amino acids. Biochem J (1977) 0.77
Structure and expression of the hepatitis B virus genome. Dev Biol Stand (1981) 0.77
Lymphadenopathy associated virus and its etiological role in AIDS. Princess Takamatsu Symp (1984) 0.77
HIV genetic variation: life at the edge. J Infect (1997) 0.76
Human immunodeficiency viruses. Too close for comfort. Nature (1990) 0.76